Detalhe da pesquisa
1.
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.
Haematologica
; 106(4): 1079-1085, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107329
2.
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
Ann Hematol
; 100(2): 437-443, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392702
3.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
Cancer
; 125(5): 750-760, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561775
4.
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
Hematol Oncol
; 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29602219
5.
Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network.
Haematologica
; 106(5): 1496-1499, 2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054135
6.
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies.
Haematologica
; 99(10): 1611-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015938
7.
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Leukemia
; 37(2): 388-395, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435884
8.
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 40(27): 3120-3131, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666982
9.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Blood Cancer J
; 11(6): 106, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083504
10.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.
Crit Rev Oncol Hematol
; 132: 9-16, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447931
11.
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.
Oncotarget
; 8(4): 5924-5935, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779105
12.
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Cytometry B Clin Cytom
; 90(1): 81-90, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26287276
13.
Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.
Immunol Lett
; 134(2): 137-44, 2011 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20923685